266 related articles for article (PubMed ID: 7908218)
41. Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.
Tsuda H; Sakamaki C; Tsugane S; Fukutomi T; Hirohashi S
Jpn J Clin Oncol; 1998 Jan; 28(1):5-11. PubMed ID: 9491134
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of c-erbB-2 oncogene in axillary node-negative breast cancer.
Molland JG; Barraclough BH; Gebski V; Milliken J; Bilous M
Aust N Z J Surg; 1996 Feb; 66(2):64-70. PubMed ID: 8602816
[TBL] [Abstract][Full Text] [Related]
43. High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.
White GR; Stack M; Santibáñez-Koref M; Liscia DS; Venesio T; Wang JC; Helms C; Donis-Keller H; Betticher DC; Altermatt HJ; Hoban PR; Heighway J
Br J Cancer; 1996 Sep; 74(6):863-70. PubMed ID: 8826850
[TBL] [Abstract][Full Text] [Related]
44. Identification of high-risk breast cancer patients from genetic changes of their tumors.
Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M
Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462
[TBL] [Abstract][Full Text] [Related]
45. The TP53 gene polymorphisms and survival of sporadic breast cancer patients.
Bišof V; Salihović MP; Narančić NS; Skarić-Jurić T; Jakić-Razumović J; Janićijević B; Rudan P
Med Oncol; 2012 Jun; 29(2):472-8. PubMed ID: 21365326
[TBL] [Abstract][Full Text] [Related]
46. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
[TBL] [Abstract][Full Text] [Related]
47. Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.
Scarpa A; Di Pace C; Talamini G; Falconi M; Lemoine NR; Iacono C; Achille A; Baron A; Zamboni G
Gut; 2000 Jun; 46(6):842-8. PubMed ID: 10807898
[TBL] [Abstract][Full Text] [Related]
48. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
49. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.
Chappell SA; Walsh T; Walker RA; Shaw JA
Br J Cancer; 1997; 75(9):1324-9. PubMed ID: 9155053
[TBL] [Abstract][Full Text] [Related]
51. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
52. Loss of heterozygosity at 11q22-q23 in breast cancer.
Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
[TBL] [Abstract][Full Text] [Related]
53. int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc.
Henry JA; Hennessy C; Levett DL; Lennard TW; Westley BR; May FE
Int J Cancer; 1993 Mar; 53(5):774-80. PubMed ID: 8449602
[TBL] [Abstract][Full Text] [Related]
54. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
Tsuda H; Fukutomi T; Hirohashi S
Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
[TBL] [Abstract][Full Text] [Related]
55. Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients.
Dobes P; Podhorec J; Coufal O; Jureckova A; Petrakova K; Vojtesek B; Hrstka R
Oncol Rep; 2014 Oct; 32(4):1695-702. PubMed ID: 25051299
[TBL] [Abstract][Full Text] [Related]
56. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
57. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
58. A region close to Tp53 shows LOH in familial breast cancer.
Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
[TBL] [Abstract][Full Text] [Related]
59. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
60. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
